Concomitant use of sorafenib with ombitasvir/paritaprevir/ritonavir and dasabuvir: Effectiveness and safety in clinical practice. [electronic resource]
Producer: 20190118Description: 906-909 p. digitalISSN:- 1365-2710
- 2-Naphthylamine
- Aged
- Anilides -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Antiviral Agents -- administration & dosage
- Carbamates -- administration & dosage
- Carcinoma, Hepatocellular -- drug therapy
- Cyclopropanes
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Humans
- Lactams, Macrocyclic
- Liver Neoplasms -- drug therapy
- Macrocyclic Compounds -- administration & dosage
- Male
- Middle Aged
- Proline -- analogs & derivatives
- Prospective Studies
- Ritonavir -- administration & dosage
- Sorafenib -- administration & dosage
- Sulfonamides -- administration & dosage
- Treatment Outcome
- Uracil -- administration & dosage
- Valine
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.